New regulations for clinical trials with medical devices postponed by one year

As a result of the COVID 19 pandemic, the revised human research legislation (including the new ordinance on clinical trials with medical devices, ClinO-MD) will not come into force until 26 May 2021. This means that the authorisation and conduct of clinical trials in general and clinical trials with medical devices in particular will continue until May 2021 in accordance with the current law of the ClinO. The postponement is harmonized with the postponement of the entry into force of the EU Medical Device Regulation (MDR). Further information can be found on the following websites: 

Research involving humans - New regulations for clinical trials with medical devices

Therapeutic Products Act - Revision of the medical devices legislation

Important information about the new coronavirus (COVID-19)

Switzerland is in an exceptional situation due to the rapid spread of the new coronavirus (COVID-19). This also has implications for human research.

Here you will find general information from the Federal Office of Public Health (FOPH) on COVID-19.

Here you will find the clinical trials on COVID-19 carried out in Switzerland or in Switzerland's vicinity abroad.

Here you will find all research projects approved in Switzerland on COVID-19 (clinical trials, non-clinical trials, projects for the further use of samples and data). 

Here you will find important information and guidance documents from swissethics (and Swissmedic) on the conduct of clinical trials during the corona crisis.